Diagnoses and Management Acute Headache Emergency Department
Diagnoses and Management Acute Headache Emergency Department
Diagnoses and Management Acute Headache Emergency Department
of
Acute Headache
in the
Emergency Department
Case I: 40 yo. F-brought to the ER by EMS, c/o severe
HA. Describes HA as pounding in nature, diffuse, sudden
onset, associated with N/V X 3 over the last several
hours. Also c/o dizziness & blurry vision.
PE: VSS-appears in moderate distress and remains
recumbent on the examination table during the entire
assessment. HEENT: PERRLA, EOMI but squints when
testing pupillary response. Resists movement when asked
to flex her neck and cries out when you attempt to assist
her with neck flexion. Neuro exam: occasional slurring
of speech and lethargy noted.
Remaining of the Physical Exam is nl.
Case II: 42 yo. F-presents to the ER stating that she is
having a migraine and is requesting narcotics for pain
relief. She has a long hx. of migraines and usually
receives an IM narcotic and is discharged home. She
would have talked to her FP for this but shes out of town.
She was placed in urgent category by the triage RN
because of stated degree of discomfort. She has received
ergotamine and imitrex in the past w/out adequate
response. Shes allergic to NSAIDs.
PE: Sitting in a dark room with polarized sunglasses.
Shes asking for pain relief and wondering aloud why you
will not give it to her.
Headache Is a Major Public Health
Problem
. Up to 4% of ED Visits / 2% All Office Visits
. Over 20 Million Outpatient Visits
. 78 % of Women and 60% of Men Experienced
at Least One Headache in the Year
. 36% of Women and 19% Men Suffered From
Recurrent Headaches
Potentially Life Threatening Etiologies
Characterize Patients Presenting to the
Emergency Department With a Chief
Complaint of a Severe Headache
in <5% of the Cases
Goals of Headache Management in the
Emergency Department
Primary
Exclude Ominous Causes
Provide Adequate Relief of Pain
Secondary
Minimize Time Spent in the ED
Establish Continuity of Care
after discharge
History
Establishing a diagnoses when a patient
presents with a headache depends almost
entirely on taking an accurate patient
history and physical exam
Age of Onset
Associated Symptoms
. GI and Neurological symptoms most common
example: eye pain, photophobia, N/V, syncope, fever,
facial pain, jaw claudication, etc.
. Aggravating or relieving
factors
CT-Scan
MRI
Lumbar Puncture
Blood Count/ESR
Headache Classification
User friendly IHS Classification
Primary Headaches
Benign Headache disorders
Migraine (with or without aura)
Tension-type headaches
Cluster headaches
Drug rebound headaches-Medication overuse headache
Secondary Headaches
Headaches that are symptoms of organic disease
Secondary Headaches
Subarachnoid Hemorrhage
Meningitis
Temporal Arteritis
Hypertension
Glaucoma
Trauma
Non-meningitic Infections
Pseudotumor Cerebri
Metabolic Disorders
Toxic Substances
Space Occupying Lesions
Sinusitis
Subarachnoid Hemorrhage
sudden onset HA unexpected clap of thunder
most common location is occipitonuchal
excruciating pain,vomiting, obtundation
Diagnosis: CT-Scan, LP (xanthochromia)
Neuroleptics/antiemetics
. Phenothiazines (Thorazine, Compazine)
. Metoclopramide (Reglan)
Dihydroergotamine (DHE)
. Broader spectrum, affects serotoninergic,
alpha-adrenergic and dopamine receptors
Sumatriptan: Imitrex
Others: Naratriptan(Amerge), almotriptan(Axert),
rizatriptan(Maxalt), frovatriptan(Frova), eletriptan(Relpax),
zolmitriptan(Zomig), etc.
D.H.E
Offers primary therapy, not just pain relief
Minimal side effects, mainly N/V
No physical dependence; non-narcotic
may be administered IV, IM, SQ and NS available
Venoconstrictor-has no arterial vasoconstrictor effects
General precautions; age over 60, DM and HTN
other side effects: leg cramps, chest tightness
DHE
IV/IM/SC: 0.25-1 mg., can be used 2-3x/day
Nasal Spray: 1 spray in each nostril (0.5 mg/spray)
may repeat in 15 mins (4 sprays=2 mg)
use no more than 2-3x/week, on separate days
Avoid use with macrolide antibiotics, in patients with
ischemic heart dz, uncontrolled HTN
Other ergotamine medications;
Ergotamine tartrate(ET): cafergot, Wigraine, etc.
available in oral, suppositories, sublingual(ergostat)
2 tabs at onset, 1-2 q30-60 mins, max. 2-6/day
no more than 2 days/week
cannot be used within 24 hours of triptan medications
Administration of D.H.E
Method I: Pretreat with 10 mg IV compazine over 2 mins
Wait app. 20 mins, administer 0.5-1.0 mg
DHE-slow IVP over 2 minutes